More on SGHT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-12.5% Growth)
- Ratings (5.6 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Sight Sciences (NQ:SGHT)
Delayed: 8.57 +0.38 (4.64%)
Prev. Close $8.19  
Open$8.02 
52 Wk High$ 
52 Wk Low$ 
Day High$8.79 
Day Low$7.82 
P/E N/A  
EPS$ 
Volume165,974 


Aug 19, 2026 07:05 AM TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
Aug 18, 2026 06:08 PM Form 4 Sight Sciences, Inc. For: Aug 10 Filed by: Rashid Kashif
Aug 18, 2026 06:08 PM Form 3 Sight Sciences, Inc. For: Aug 10 Filed by: Rashid Kashif
Aug 17, 2026 04:23 PM Form 144 Sight Sciences, Inc. Filed by: HAYDEN JEREMY B.
Aug 14, 2026 04:35 PM Form 144 Sight Sciences, Inc. Filed by: HAYDEN JEREMY B.
Aug 13, 2026 02:08 PM Form 144 Sight Sciences, Inc. Filed by: HAYDEN JEREMY B.
Aug 12, 2026 02:18 PM Form 144 Sight Sciences, Inc. Filed by: HAYDEN JEREMY B.
Aug 11, 2026 03:53 PM Form 144 Sight Sciences, Inc. Filed by: HAYDEN JEREMY B.
Aug 10, 2026 08:22 AM Form 8-K Sight Sciences, Inc. For: Aug 06
Aug 6, 2026 02:46 AM Sight Sciences, Inc. (SGHT) Tops Q2 EPS by 7c
View All Articles

Entities mentioned with SGHT

View All Entities